| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/01/1998 | EP0831816A1 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia |
| 04/01/1998 | EP0831815A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers |
| 04/01/1998 | EP0831814A1 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers |
| 04/01/1998 | EP0831809A1 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 04/01/1998 | EP0831806A1 Multidentate metal complexes and methods of making and using thereof |
| 04/01/1998 | EP0831800A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS |
| 04/01/1998 | EP0644759A4 Production and use of imines of porphyrins. |
| 04/01/1998 | CN1177961A 10 -deacetyl-14 beta-hydroxybaccatine III derivatives, a process for the preparation thereof and formulations containing them |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 04/01/1998 | CN1177485A Oral liquor for treating tumour and disease of liver, and preparation method thereof |
| 03/31/1998 | US5734056 Process for the preparation of certain 9-substituted camptothecins |
| 03/31/1998 | US5734046 Method for manufacturing limonoid glucosides |
| 03/31/1998 | US5734037 DNA encoding the human cytokine, interleukin-9 |
| 03/31/1998 | US5734013 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
| 03/31/1998 | US5733927 Antitumor agents and immunology |
| 03/31/1998 | US5733918 Condensed-Indan derivatives and pharmaceutically acceptable salts thereof |
| 03/31/1998 | US5733913 Treating atherosclerosis, postsurgical restenosis |
| 03/31/1998 | US5733911 Antitumor agents and anticarcinogenic agents |
| 03/31/1998 | US5733903 Treatment of neoplastic tissue by water-soluble texaphyrine metal complexes |
| 03/31/1998 | US5733902 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors |
| 03/31/1998 | US5733896 Viricide for retrovirus |
| 03/31/1998 | US5733893 Binding of fibroblast growth factor to oligosaccharides |
| 03/31/1998 | US5733880 Anthracene derivatives for use as anticancer agents |
| 03/31/1998 | US5733876 Method of inhibiting angiogenesis |
| 03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 03/31/1998 | US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 03/31/1998 | US5733548 Stimulating t-cell response |
| 03/26/1998 | WO1998012325A1 Human gtp binding protein gamma-3 |
| 03/26/1998 | WO1998012319A1 Broad spectrum therapeutic peptide |
| 03/26/1998 | WO1998012223A1 Novel human interferon-inducible protein |
| 03/26/1998 | WO1998012220A2 Novel tumor proteins |
| 03/26/1998 | WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | WO1998012204A1 Human b-cell translocation genes-2 and 3 |
| 03/26/1998 | WO1998012198A1 Process for producing ecteinascidin compounds |
| 03/26/1998 | WO1998012197A1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates |
| 03/26/1998 | WO1998012181A1 Substituted heterocycles as anti-tumor agents |
| 03/26/1998 | WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | WO1998011911A1 Use of cytokines and cytotoxic substances in a new method to treat tumors |
| 03/26/1998 | WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/26/1998 | WO1998011905A1 Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process |
| 03/26/1998 | WO1998011898A1 Reducing toxic effects of carboplatin using dithioethers |
| 03/26/1998 | WO1997046672A3 Antisense nucleic acids and hammerhead ribozymes |
| 03/26/1998 | WO1997043272A3 Benzofurans and benzopyrans as chronobiological agents |
| 03/26/1998 | DE19704301C1 Human endoglin gene promoter |
| 03/26/1998 | DE19639103A1 DNA construct with inhibitory mutation and corrective mutation |
| 03/26/1998 | CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | CA2266505A1 Intermediates of duocarmycin sa and its derivatives and methods for producing the same |
| 03/26/1998 | CA2266425A1 Human b-cell translocation genes-2 and 3 |
| 03/26/1998 | CA2266321A1 Substituted heterocycles as anti-tumor agents |
| 03/26/1998 | CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/26/1998 | CA2264542A1 Human gtp binding protein gamma-3 |
| 03/26/1998 | CA2263821A1 Novel human interferon-inducible protein |
| 03/26/1998 | CA2263818A1 Novel tumor proteins |
| 03/25/1998 | EP0830604A1 Methods and uses for apoptin |
| 03/25/1998 | EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein |
| 03/25/1998 | EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability |
| 03/25/1998 | EP0830360A1 Cytotoxic macrolides |
| 03/25/1998 | EP0830357A1 Radiosensitizing diamines and their pharmaceutical preparations |
| 03/25/1998 | EP0830145A1 Formulations for lipophilic compounds |
| 03/25/1998 | EP0830137A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 03/25/1998 | EP0830136A1 New cryptophycins from synthesis |
| 03/25/1998 | CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof |
| 03/25/1998 | CN1177303A Application of lysozyme dimer |
| 03/25/1998 | CN1177302A Lymphotoxin- |
| 03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
| 03/25/1998 | CN1176795A Traditional Chinese medicine- |
| 03/25/1998 | CN1037844C Tnf-muteins |
| 03/24/1998 | US5731441 Hydroxamic acid derivatives with tricyclic substitution |
| 03/24/1998 | US5731351 Antiarrhythmia agents |
| 03/24/1998 | US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/24/1998 | US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens |
| 03/24/1998 | US5731301 Bistriazenes as chemotherapeutic agents |
| 03/24/1998 | US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides |
| 03/24/1998 | US5731289 Bridged dipeptide compounds which have a stimulating activity on cell division, especially in myelopoietic and bone marrow cells |
| 03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
| 03/24/1998 | US5730981 Monoclonal anti-ganglioside antibody and its preparation |
| 03/24/1998 | US5730759 Poly-substituted phthalocyanines |
| 03/24/1998 | CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy |
| 03/24/1998 | CA1339770C Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
| 03/19/1998 | WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 03/19/1998 | WO1998011227A1 Granulocyte chemotactic protein 2 variant |
| 03/19/1998 | WO1998011224A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods |
| 03/19/1998 | WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 03/19/1998 | WO1998011212A1 Ptx sensitive g proteins, the production and use thereof |
| 03/19/1998 | WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY |
| 03/19/1998 | WO1998011202A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids |
| 03/19/1998 | WO1998011135A1 A taxol-like protein (talp) and process for preparing the same |
| 03/19/1998 | WO1998011106A1 Tricyclic compounds useful as fpt inhibitors |
| 03/19/1998 | WO1998011101A2 Condensed n-aclyindoles as antitumor agents |
| 03/19/1998 | WO1998011100A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 03/19/1998 | WO1998011099A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 03/19/1998 | WO1998011098A1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase |
| 03/19/1998 | WO1998011097A1 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase |
| 03/19/1998 | WO1998011096A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/19/1998 | WO1998011095A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors |
| 03/19/1998 | WO1998011093A1 Tricyclic inhibitors of farnesyl protein transferase |
| 03/19/1998 | WO1998011092A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/19/1998 | WO1998011091A2 Tricyclic compounds useful for inhibition of farnesyl protein transferase |